Compare TRTX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRTX | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.4M | 554.2M |
| IPO Year | N/A | 2009 |
| Metric | TRTX | CLPT |
|---|---|---|
| Price | $8.40 | $18.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $9.83 | ★ $20.00 |
| AVG Volume (30 Days) | 698.7K | ★ 892.4K |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | ★ 11.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $8.78 | $45.67 |
| Revenue Next Year | $4.14 | $19.51 |
| P/E Ratio | $14.82 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $7.57 | $8.27 |
| 52 Week High | $9.85 | $30.10 |
| Indicator | TRTX | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 66.53 |
| Support Level | $8.35 | $12.55 |
| Resistance Level | $8.72 | $27.64 |
| Average True Range (ATR) | 0.15 | 1.47 |
| MACD | -0.02 | 0.17 |
| Stochastic Oscillator | 30.61 | 86.13 |
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.